Comparison of Low-Dose and Standard-Dose Intravenous Immunoglobulin for Treating Generalized Myasthenia Gravis: A Prospective Cohort Study at a Single Center - Top-Institutions - MDSpire

Comparison of Low-Dose and Standard-Dose Intravenous Immunoglobulin for Treating Generalized Myasthenia Gravis: A Prospective Cohort Study at a Single Center

  • By

  • Haocheng Luo

  • Li Dong

  • Li Yang

  • Yufei Deng

  • Chaoyue Zhang

  • Xuxiang Zhang

  • Liqing Hu

  • Zhenyu Wu

  • Xiaojun Yang

  • Qilong Jiang

  • April 28, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Neuromuscular Medicine

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Clinical Research

  • #3

    University of Pennsylvania (Penn Medicine)
    University of Pennsylvania (Penn Medicine)

    Philadelphia, PA

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Autoimmune Disorders

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Neuromuscular Medicine

  • #5

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Autoimmune Neurology

Original Source(s)

Comparison of Low-Dose and Standard-Dose Intravenous Immunoglobulin for Treating Generalized Myasthenia Gravis: A Prospective Cohort Study at a Single Center

  • by Haocheng Luo, Li Dong, Li Yang, Yufei Deng, Chaoyue Zhang, Xuxiang Zhang, Liqing Hu, Zhenyu Wu, Xiaojun Yang, Qilong Jiang

  • April 28, 2026

Related Content

AAP, NASPGHAN Issue Guidance on Faltering Weight in Children

New recommendations standardize diagnosis and aim to reduce unnecessary interventions in early childhood growth concerns.

Disease-specific divergence of inflammatory and metabolic biomarkers in neurocritical neuromuscular disorders

Multimodal Brain Monitoring May Improve ICU Outcomes

Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.